The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Reckitt Benckiser Group plc (“Reckitt” or “the Company”) (OTC: RBGLY) for violations of the securities laws.
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), a shareholder and consumer rights litigation firm, is investigating whether Reckitt Benckiser Group PLC (“Reckitt” or the “Company”) (OTC: RBGLY) or certain of its officers and directors issued misleading and false statements, and/or failed to disclose information material to investors in violation of federal securities laws.
FDA proposes removing oral phenylephrine from OTC drugs for nasal congestion, citing ineffectiveness. Public comments open before a final order is issued.
Piper Sandler initiates coverage on Abbott with an Overweight rating, citing its diversified business model, strong medtech growth and attractive valuation.
Reckitt Benckiser is reportedly in early talks to sell its homecare division, featuring brands like Air Wick and Calgon, as part of a broader strategy to focus on consumer health and hygiene. The sale could be valued at over £6 billion.
This verdict is part of nearly 1,000 lawsuits filed against Abbott Labs, its British rival Reckitt Benckiser, or both, in U.S. federal or state courts.
Abbott faces trial over claims its baby formula causes necrotizing enterocolitis in preterm infants. This is the second trial among hundreds of similar lawsuits, impacting Abbott and Reckitt Benckiser.
An Illinois jury orders Reckitt Benckiser's Mead Johnson to pay $60 million after a premature infant's tragic death linked to Enfamil baby formula. Mead Johnson found negligent for not warning about NEC risks. Over 400 NEC lawsuits pending in federal court in Chicago.
Reckitt Benckiser Group is leveraging the popularity of livestream shopping in China to sell condoms, a move that could be challenging due to strict regulatory oversight.
A massive recall of hypoallergenic infant formula has been initiated due to concerns over potential bacteria contamination. The recall involves approximately 675,000 cans of infant formula.
According to FDA panel experts who reviewed the latest research on the long-questioned phenylephrine, a drug ingredient used in several leading decongestants used by millions of Americans looking for relief from
Between Covid, the flu, and RSV, investors in over-the-counter consumer pharmaceutical companies might be wondering if now is a logical time to up their holdings in the companies that make cold and flu medicines. Let’s take a look.
One of the larger companies in the UK, parts of which have been around for 200+ years, is Reckitt Benckiser Group plc. I like to think of it as the Procter & Gamble of the UK.
On Friday, shares of Reckitt Benckiser Group plc (OTC: RBGLY) experienced volatile short activity. After the activity, the stock price went down -1.96% to $14.48. The overall sentiment for RGBLY has been Bearish.
